| 2024 | 2023 | |||
|---|---|---|---|---|
| Gross margin | -189,3 k € | -72.8% | -109,6 k € | |
| EBITDA | -189,7 k € | -72.5% | -109,9 k € | |
| Operating profit | -189,7 k € | -72.5% | -109,9 k € | |
| Profit/loss | -190,1 k € | -71.1% | -111,1 k € | |
| Equity | -291,1 k € | -188.0% | -101,1 k € | |
| Total assets | 9,6 k € | -95.2% | 200,5 k € | |
| Cash | 6,1 k € | -96.7% | 187,1 k € | |
| Debts | 300,7 k € | -0.3% | 301,6 k € | |
Private limited company · Charleroi · incorporated on 24/03/2023
Private limited company loss-making in the latest fiscal year. Cash position declining (-96.7%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
INCHINN THERAPEUTICS is a Private limited company incorporated in 2023. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Charleroi.